Table 2.
Angiographic and procedural features of the two groups.
| Variable |
Danlou Tablet group (n = 109) |
Placebo group (n = 110) |
χ 2 (Z) | p value |
|---|---|---|---|---|
| Multivessel coronary artery disease, number (%) | 62 (56.9) | 63 (57.3) | 0.00 | 0.95 |
| Vessel treated, number (%) | ||||
| Left main | 2 (1.8) | 2 (1.8) | 1.00∗ | |
| Left anterior descending | 73 (67.0) | 65 (59.1) | 1.46 | 0.23 |
| Left circumflex | 26 (23.9) | 34 (30.9) | 1.37 | 0.24 |
| Right coronary artery | 35 (32.1) | 30 (27.3) | 0.61 | 0.43 |
| Restenotic lesions, number (%) | 1 (0.9) | 1 (0.9) | 1.00 | |
| Multivessel intervention, number (%) | 24 (22.0) | 18 (16.4) | 1.13 | 0.29 |
| Type of intervention, number (%) | ||||
| Balloon only | 1 (0.9) | 1 (0.9) | 1.00∗ | |
| Stent | 108 (99.1) | 109 (99.1) | 1.00∗ | |
| Number of stents per patient | 1.49 ± 0.70 | 1.41 ± 0.67 | −0.89 | 0.37 |
| Stent diameter, mm | 2.94 ± 0.43 | 2.92 ± 0.43 | −0.87 | 0.39 |
| Total stent length, mm | 20.52 ± 7.01 | 22.37 ± 7.46 | −2.34 | 0.02 |
Values are given as number of patients (%) or mean ± SD. ∗ p value is from Fisher's exact test.